These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1279 related items for PubMed ID: 19207079

  • 1. Initial low-dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxic.
    Cosgrove SE, Vigliani GA, Fowler VG, Abrutyn E, Corey GR, Levine DP, Rupp ME, Chambers HF, Karchmer AW, Boucher HW.
    Clin Infect Dis; 2009 Mar 15; 48(6):713-21. PubMed ID: 19207079
    [Abstract] [Full Text] [Related]

  • 2. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus.
    Fowler VG, Boucher HW, Corey GR, Abrutyn E, Karchmer AW, Rupp ME, Levine DP, Chambers HF, Tally FP, Vigliani GA, Cabell CH, Link AS, DeMeyer I, Filler SG, Zervos M, Cook P, Parsonnet J, Bernstein JM, Price CS, Forrest GN, Fätkenheuer G, Gareca M, Rehm SJ, Brodt HR, Tice A, Cosgrove SE, S. aureus Endocarditis and Bacteremia Study Group.
    N Engl J Med; 2006 Aug 17; 355(7):653-65. PubMed ID: 16914701
    [Abstract] [Full Text] [Related]

  • 3. Cost-Effectiveness of daptomycin versus vancomycin and gentamicin for patients with methicillin-resistant Staphylococcus aureus bacteremia and/or endocarditis.
    Bhavnani SM, Prakhya A, Hammel JP, Ambrose PG.
    Clin Infect Dis; 2009 Sep 01; 49(5):691-8. PubMed ID: 19635023
    [Abstract] [Full Text] [Related]

  • 4. Lack of evidence associating nephrotoxicity with low-dose gentamicin for Staphylococcus aureus bacteremia and endocarditis.
    Bruss JB.
    Clin Infect Dis; 2009 Sep 01; 49(5):806; author reply 807-8. PubMed ID: 19653850
    [No Abstract] [Full Text] [Related]

  • 5. Clinical outcomes of patients receiving daptomycin for the treatment of Staphylococcus aureus infections and assessment of clinical factors for daptomycin failure: a retrospective cohort study utilizing the Cubicin Outcomes Registry and Experience.
    Sakoulas G, Brown J, Lamp KC, Friedrich LV, Lindfield KC.
    Clin Ther; 2009 Sep 01; 31(9):1936-45. PubMed ID: 19843483
    [Abstract] [Full Text] [Related]

  • 6. Safety and clinical outcomes when utilizing high-dose (> or =8 mg/kg) daptomycin therapy.
    Moise PA, Hershberger E, Amodio-Groton MI, Lamp KC.
    Ann Pharmacother; 2009 Jul 01; 43(7):1211-9. PubMed ID: 19584384
    [Abstract] [Full Text] [Related]

  • 7. Retrospective observational study comparing vancomycin versus daptomycin as initial therapy for Staphylococcus aureus infections.
    Jobson S, Moise PA, Eskandarian R.
    Clin Ther; 2011 Oct 01; 33(10):1391-9. PubMed ID: 22015328
    [Abstract] [Full Text] [Related]

  • 8. Severity of gentamicin's nephrotoxic effect on patients with infective endocarditis: a prospective observational cohort study of 373 patients.
    Buchholtz K, Larsen CT, Hassager C, Bruun NE.
    Clin Infect Dis; 2009 Jan 01; 48(1):65-71. PubMed ID: 19046065
    [Abstract] [Full Text] [Related]

  • 9. Methicillin-resistant Staphylococcus aureus prosthetic aortic valve endocarditis with paravalvular abscess treated with daptomycin.
    Mohan SS, McDermott BP, Cunha BA.
    Heart Lung; 2005 Jan 01; 34(1):69-71. PubMed ID: 15647736
    [Abstract] [Full Text] [Related]

  • 10. Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study.
    Chang FY, Peacock JE, Musher DM, Triplett P, MacDonald BB, Mylotte JM, O'Donnell A, Wagener MM, Yu VL.
    Medicine (Baltimore); 2003 Sep 01; 82(5):333-9. PubMed ID: 14530782
    [Abstract] [Full Text] [Related]

  • 11. Successful treatment of daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus bacteremia with the addition of rifampin to daptomycin.
    Ahmad NM, Rojtman AD.
    Ann Pharmacother; 2010 May 01; 44(5):918-21. PubMed ID: 20354160
    [Abstract] [Full Text] [Related]

  • 12. Daptomycin versus vancomycin plus gentamicin for treatment of bacteraemia and endocarditis due to Staphylococcus aureus: subset analysis of patients infected with methicillin-resistant isolates.
    Rehm SJ, Boucher H, Levine D, Campion M, Eisenstein BI, Vigliani GA, Corey GR, Abrutyn E.
    J Antimicrob Chemother; 2008 Dec 01; 62(6):1413-21. PubMed ID: 18782781
    [Abstract] [Full Text] [Related]

  • 13. Daptomycin for the treatment of gram-positive bacteremia and infective endocarditis: a retrospective case series of 31 patients.
    Segreti JA, Crank CW, Finney MS.
    Pharmacotherapy; 2006 Mar 01; 26(3):347-52. PubMed ID: 16503714
    [Abstract] [Full Text] [Related]

  • 14. Activities of antistaphylococcal antibiotics towards the extracellular and intraphagocytic forms of Staphylococcus aureus isolates from a patient with persistent bacteraemia and endocarditis.
    Lemaire S, Kosowska-Shick K, Julian K, Tulkens PM, Van Bambeke F, Appelbaum PC.
    Clin Microbiol Infect; 2008 Aug 01; 14(8):766-77. PubMed ID: 18727801
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Clinical outcomes and nephrotoxicity associated with vancomycin trough concentrations during treatment of deep-seated infections.
    Hermsen ED, Hanson M, Sankaranarayanan J, Stoner JA, Florescu MC, Rupp ME.
    Expert Opin Drug Saf; 2010 Jan 01; 9(1):9-14. PubMed ID: 20021290
    [Abstract] [Full Text] [Related]

  • 17. A randomized clinical trial to compare fleroxacin-rifampicin with flucloxacillin or vancomycin for the treatment of staphylococcal infection.
    Schrenzel J, Harbarth S, Schockmel G, Genné D, Bregenzer T, Flueckiger U, Petignat C, Jacobs F, Francioli P, Zimmerli W, Lew DP, Swiss Staphylococcal Study Group.
    Clin Infect Dis; 2004 Nov 01; 39(9):1285-92. PubMed ID: 15494904
    [Abstract] [Full Text] [Related]

  • 18. Successful salvage therapy with daptomycin after linezolid and vancomycin failure in a liver transplant recipient with methicillin-resistant Staphylococcus aureus endocarditis.
    Vernadakis S, Saner FH, Rath PM, Kaiser GM, Mathe Z, Treckmann J, Paul A.
    Transpl Infect Dis; 2009 Aug 01; 11(4):346-8. PubMed ID: 19497075
    [Abstract] [Full Text] [Related]

  • 19. Bacteremia and infective endocarditis caused by a non-daptomycin-susceptible, vancomycin-intermediate, and methicillin-resistant Staphylococcus aureus strain in Taiwan.
    Huang YT, Hsiao CH, Liao CH, Lee CW, Hsueh PR.
    J Clin Microbiol; 2008 Mar 01; 46(3):1132-6. PubMed ID: 18199793
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 64.